All terms in BMONT

Label Id Description
rheumatoid arthritis MONDO_0008383 [A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.]
autoimmune disease DOID_417 [An immune system disease that is an overactive immune response of the body against substances and tissues normally present in the body resulting from an abnormal functioning of the immune system that results in the production of antibodies or T cell directed against the host tissues.]
Monitoring NCIT_C61256 [The act of observing something (and sometimes keeping a record of it).]
process BFO_0000015 [p is a process = Def. p is an occurrent that has temporal proper parts and for some time t, p s-depends_on some material entity at t. (axiom label in BFO2 Reference: [083-003])]
cancer marker OPMI_0000464
disease biomarker OPMI_0000450 [A biomarker that is indicative of a disease]
celiac disease DOID_10608 [An autoimmune disease of gastrointestinal tract that is caused by a reaction located_in small intestine to gliadin, a prolamin (gluten protein) found in wheat, and similar proteins found in the crops of the tribe Triticeae. The disease is associated with HLA-DQ gene. It has_symptom abdominal pain, has_symptom constipation, has_symptom diarrhea, has_symptom nausea and vomiting, and has_symptom loss of appetite.]
Pharmacodynamic Biomarker NCIT_C201365 [A response biomarker that indicates biologic activity of a medical product or environmental agent without necessarily drawing conclusions about efficacy or disease outcome or necessarily linking this activity to an established mechanism of action. (NIH-FDA BEST (Biomarkers, Endpoints, and other Tools) Resource)]
Response Biomarker NCIT_C201303 [A biomarker used to show that a biological response, potentially beneficial or harmful, has occurred in an individual who has been exposed to a medical product or an environmental agent. (NIH-FDA BEST (Biomarkers, Endpoints, and other Tools) Resource)]
saliva UBERON_0001836 [A fluid produced in the oral cavity by salivary glands, typically used in predigestion, but also in other functions.]
organism substance UBERON_0000463 [Material anatomical entity in a gaseous, liquid, semisolid or solid state; produced by anatomical structures or derived from inhaled and ingested substances that have been modified by anatomical structures as they pass through the body.]
proteinuria DOID_576 [A kidney disease that is characterized by the presence of excess proteins in the urine.]
kidney disease DOID_557 [A urinary system disease that is located_in the kidney.]
Monitoring Biomarker NCIT_C201362 [A biomarker measured repeatedly for assessing status of a disease or medical condition or for evidence of exposure to (or effect of) a medical product or an environmental agent. (NIH-FDA BEST (Biomarkers, Endpoints, and other Tools) Resource)]
biomarker OPMI_0000445 [A material entity that has a measurable quality or process profile(s), which can be used as an indicator of an underlying biological state or identity.]
biological feature MI_0252 [Property of a subsequence that may be involved with or interfere with the binding of a molecule and are supported by experimental evidences.]
quality BFO_0000019
metabolic syndrome EFO_0000195 [A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)]
disease of metabolism DOID_0014667 [A disease that involving errors in metabolic processes of building or degradation of molecules.]
malignant EFO_0006851 [Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host]